SCHEMBL31232401

SCHEMBL31232401

CSCC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O)C(C)C

nearest known ligand 0.62

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 4/20 0.62
▸ GCGR P47871 1/20 0.62
▸ GIPR P48546 1/20 0.62
▸ IL23R Q5VWK5 2/20 0.58
▸ CCKBR P32239 8/20 0.57
▸ ECE1 P42892 1/20 0.54
▸ MUS81 Q96NY9 1/20 0.54
▸ PTH1R Q03431 1/20 0.54
▸ CXCL8 P10145 2/20 0.54
▸ BACE1 P56817 1/20 0.54
▸ BACE2 Q9Y5Z0 1/20 0.54
▸ KISS1R Q969F8 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31683350 0.88 CCKBR (0.65) GLP1RGCGRGIPRIL23RCCKBR
SCHEMBL29714715 0.88 BACE1 (0.58) BACE1BACE2
SCHEMBL30522055 0.88 ERBB2 (0.55) GLP1RGCGRGIPRCCKBRPTH1R
SCHEMBL31683263 0.87 GLP1R (0.59) GLP1RGCGRGIPRIL23RCCKBR
SCHEMBL30567695 0.87 GLP1R (0.62) GLP1RGCGRCCKBR
SCHEMBL30753147 0.86 GLP1R (0.77) GLP1RGCGRGIPRIL23RCCKBR
SCHEMBL30906347 0.86 GLP1R (0.56) GLP1RGCGRGIPRECE1MUS81
SCHEMBL30726544 0.86 GLP1R (0.62) GLP1RGCGRGIPRECE1MUS81
SCHEMBL30648454 0.86 GLP1R (0.69) GLP1RGCGRGIPRIL23RCCKBR
SCHEMBL31020885 0.85 IL23R (0.64) GLP1RGCGRGIPRIL23RCCKBR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642492-A1 AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES Hangzhou Seehe Biotechnology Co., Ltd (CN) 2025-11-05 — — EP claimed
WO-2024240173-A1 AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) 2024-11-28 — — WO claimed
Send feedback